Added to YB: 2026-09-18
Pitch date: 2026-09-15
MDAI [neutral]
Spectral AI, Inc.
Author Info
No bio for this author
Company Info
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
Market Cap
$51.2M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.15
P/E
-4.77
EV/Sales
3.47
Sector
Health Care Equipment and Supplies
Category
growth
Biotech Conference Coverage: Week 2, Day 1 — Part 3 - Spectral AI, Inc.
MDAI (quick overview): Spectral AI is entering commercial proof after FDA De Novo clearance for DeepView, its AI burn-assessment system. BARDA support includes funding and expected subsidies for the first 30 U.S. placements, while commercialization targets roughly 130 burn centers through device sales and recurring software revenue; its regulatory foothold and data moat could also attract a larger wound-care, surgical, imaging or AI-healthcare buyer. The key risk is whether hospitals will adopt and pay without proven workflow, reimbursement and health-economic support; MDAI had $14.0M cash versus $14.9M debt at Q2 2026.
Read full article (2 min)